Using Proenkephalin as a Novel Biomarker to Estimate GFR

Peter Pickkers is Professor of Intensive Care Medicine at the Radboud University Medical Center Nijmegen, the Netherlands. He qualified as MD (1991) and completed his residency in Internal and Intensive Care Medicine at the Radboud University Nijmegen. In 2000 he received his doctorate, titled ‘Vascular effects of diuretics’, cum laude. His research focuses on pharmacological modulation of the innate immune response in translational models and patients, and the consequences for organ function, with a focus on the kidney and brain. Up to now, he co-authored over 500 articles and over 30 book chapters and 29 PhD projects were completed under his supervision.

With over 2000 human endotoxemia experiments performed, he leads the most active group using this human in vivo model of inflammation worldwide. He has given invited lectures at all major meetings in the field of intensive care medicine and nephrology. He cooperates with various international experts in the field of sepsis and nephrology and has participated in several guidelines and steering committees.

He is on the editorial board of Intensive Care Medicine, Intensive Care Medicine Experimental and Shock. He is co-founder and chair of SepsisNet, a national organization to improve awareness of sepsis (2017-present), and co-founder and executive board member Research Collaboration in Critical Care in the Netherlands (RCCNet) (2018-present).